Trius Therapeutics, Inc. (TSRX)

[LongRun8]

KK,

Thanks for replying to my post earlier.

Also, what do you mean by the following quote:

This is where the risk is. Cubist may choose not to go after 10% which means these shares will be difficult to trade in Nasdaq.

If one doesn't tender the shares and is among the 10% or whatever the number ends up being that don't tender shares (i.e. 10%, 15%, etc) and the deal falls apart wouldn't everybody's shares be tradeable again? Why would they pay for the 90% of the share count (or whatever # that turns out to be who tendered) until everything is finalized and approved. Why would Cubist buy the shares and then risk the deal falling apart? Is that really what's going to happen?